Bridgepoint Group’s (BPT) Buy Rating Reiterated at Berenberg Bank

Berenberg Bank reiterated their buy rating on shares of Bridgepoint Group (LON:BPT) in a report released on Friday morning, Marketbeat Ratings reports. They currently have a GBX 360 price objective on the stock.

Separately, Citigroup decreased their target price on shares of Bridgepoint Group from GBX 415 to GBX 395 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of GBX 390.

Bridgepoint Group Price Performance

BPT stock opened at GBX 317.60 on Friday. The firm’s fifty day simple moving average is GBX 269.72 and its 200-day simple moving average is GBX 261.86. The company has a market capitalization of £2.78 billion, a P/E ratio of 64.82, a price-to-earnings-growth ratio of 0.61 and a beta of 1.37. The company has a debt-to-equity ratio of 53.71, a current ratio of 16.31 and a quick ratio of 3.60. Bridgepoint Group has a 12 month low of GBX 212 and a 12 month high of GBX 363.40.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.